Retractable Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVP research report →
Companywww.retractable.com
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
- CEO
- Thomas J. Shaw
- IPO
- 2001
- Employees
- 221
- HQ
- Little Elm, TX, US
Price Chart
Valuation
- Market Cap
- $19.88M
- P/E
- -3.16
- P/S
- 0.54
- P/B
- 0.28
- EV/EBITDA
- -48.14
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.20%
- Op Margin
- -61.02%
- Net Margin
- -16.93%
- ROE
- -8.45%
- ROIC
- -17.76%
Growth & Income
- Revenue
- $38.27M · 15.78%
- Net Income
- $-12,565,230 · -5.71%
- EPS
- $-0.43 · -7.50%
- Op Income
- $-20,220,815
- FCF YoY
- 41.52%
Performance & Tape
- 52W High
- $1.14
- 52W Low
- $0.60
- 50D MA
- $0.68
- 200D MA
- $0.77
- Beta
- 1.25
- Avg Volume
- 64.22K
Get TickerSpark's AI analysis on RVP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 14, 25 | SHAW THOMAS J | buy | 5,731 |
| Nov 11, 25 | SHAW THOMAS J | buy | 100 |
| Nov 5, 25 | SHAW THOMAS J | buy | 7,500 |
| Oct 30, 25 | SHAW THOMAS J | buy | 15,000 |
| Oct 28, 25 | SHAW THOMAS J | buy | 35,000 |
| Oct 27, 25 | SHAW THOMAS J | buy | 34,506 |
| Oct 23, 25 | SHAW THOMAS J | buy | 356 |
| Oct 22, 25 | SHAW THOMAS J | buy | 10,000 |
| Oct 14, 25 | SHAW THOMAS J | buy | 14,204 |
| Oct 8, 25 | SHAW THOMAS J | buy | 30,000 |
Our RVP Coverage
We haven't published any research on RVP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RVP Report →